Kevin M. Lalande, Director at LUMOS PHARMA, INC. (LUMO), bought 93,000 shares at $7.55 ($724K) on 2021-08-12, disclosed to the SEC on 2021-08-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.55 | 31,000 | $234K | 32.3% |
| 2 | $7.86 | 31,000 | $244K | 33.6% |
| 3 | $7.96 | 31,000 | $247K | 34.1% |
| Total | $7.79 avg | 93,000 | $724K | 100% |
| Filing → |
| LUMO | BUY | 2021-09-07 | $274K | — | Filing → |
| LUMO | BUY | 2021-09-01 | $269K | — | Filing → |
| LUMO | BUY | 2021-08-27 | $314K | — | Filing → |